Page last updated: 2024-08-24

lercanidipine and Hypertension

lercanidipine has been researched along with Hypertension in 140 studies

Research

Studies (140)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (2.86)	18.2507
2000's	69 (49.29)	29.6817
2010's	63 (45.00)	24.3611
2020's	4 (2.86)	2.80

Authors

Authors	Studies
Corsini, A; Ferri, N; Pontremoli, R	1
Franczyk, B; Fularski, P; Hajdys, J; Leszto, K; Majchrowicz, G; Młynarska, E; Rysz, J; Stabrawa, M	1
Abdessayed, N; Anoun, J; Ben Salem, C; Ben-Sayed, N; Fathallah, N; Ouni, B; Slim, R	1
Alegre, F; Basualdo, JE; Fernández-Ros, N; Huerta, A; Landecho, MF; Lucena, JF; Morales, MI; Rosado, IA	1
Agabiti Rosei, C; Agabiti Rosei, E; Bertacchini, F; Brami, V; Caletti, S; Coschignano, MA; De Ciuceis, C; Duse, S; Muiesan, ML; Paini, A; Petelca, A; Rizzoni, D; Rossini, C; Salvetti, M; Semeraro, F; Trapletti, V	1
Afonicheva, II; Beloborodova, AV; Melnik, MV	1
Castiglioni, P; Faini, A; Omboni, S; Parati, G	1
Mancia, G; Tsioufis, K	1
Balthazar Nardotto, GH; Barbosa Coelho, E; Dantas, M; Hanauer Schaab, E; Lanchote, VL; Marques Pereira, MP; Paiva, CE	1
Farah, R; Khamisy-Farah, R; Shurtz-Swirski, R	1
An, WS; Chen, GH; Chen, T; Li, JD; Yang, TS; Zhang, XX; Zhong, ZY	1
Elhebir, ES; Hilmi, SC; Hughes, JD	1
Maksimov, ML; Malykhina, AI	1
Burnier, M	1
Cao, Z; Chen, L; Su, C; Tao, J; Wang, Y; Xia, WH; Xie, WL; Xu, SY; Yu, BB; Zhang, B; Zhang, XY	1
Caimi, L; Cancarini, A; De Ciuceis, C; Duse, S; La Boria, E; Muiesan, ML; Paini, A; Ricotta, D; Rizzoni, D; Rosei, CA; Rosei, EA; Rossini, C; Ruggeri, G; Salvetti, M; Sarkar, A; Semeraro, F	1
Ghodake, VN; Korabu, SS; Ranpise, NS	1
Bianchi, L; Bonaventura, A; D'Angelo, A; Derosa, G; Fogari, E; Maffioli, P; Romano, D	2
Agabiti Rosei, E; De Ciuceis, C; Di Gregorio, J; Donini, C; Flati, V; La Boria, E; Pasini, E; Petroboni, B; Porteri, E; Rizzoni, D; Rossini, C; Rufo, A	1
Minushkina, LO	1
Maldonado, J; Pereira, T; Tavares, A	1
Ausheva, AK; Karpova, AV; Pogosova, GV; Salbieva, AO	1
Chazova, I; Coca, A; Girerd, X; Haller, H; Mancia, G; Pauletto, P; Pupek-Musialik, D; Svyshchenko, Y	1
Dumitriu, AS; Gheorghiu, IM; Mironiuc-Cureu, M; Stoian, IM	1
Yang, Z	1
Arnaout, S	1
Dong, H; Jiang, XJ; Peng, M; Wu, HY; Yang, Y; Zhang, HM; Zou, YB	1
Dai, Q; Gong, J; Jin, H; Lu, X; Peng, J; Wang, B; Wang, H; Wu, Y; Xu, M; Xu, X; Yan, J; Zhang, M; Zhao, S	2
Cao, TS; Huynh, VM; Tran, VH	1
Zanchetti, A	1
Angeloni, E; Lombardo, P; Pirelli, M; Refice, S; Vitaterna, A	1
Dolidze, NM; Gezeli, TD; Tabidze, GA; Tsibadze, TA	1
Bruno, RM; Cartoni, G; Ferri, C; Ghiadoni, L; Grassi, D; Magagna, A; Stea, F; Taddei, S; Virdis, A	1
Ahn, JC; Ahn, T; Cha, DH; Cho, JH; Cho, SW; Choi, DJ; Hong Baek, S; Hong, S; Hong, TJ; Jeon, ES; Jeon, HK; Jeong, JO; Jeong, MH; John, SH; Juhn, JH; Kang, JH; Kim, BS; Kim, DW; Kim, JJ; Kim, MH; Kim, NH; Kim, SK; Kim, SW; Kim, SY; Kim, YN; Kwan, J; Lee, HY; Lee, NH; Lee, SH; Lee, SY; Lee, YJ; Na, SH; Oh, BH; Park, CG; Park, SH; Park, WJ; Rhee, MY; Ryu, JK; Shin, ES; Shin, JH; Uk Lee, S; Won, KH; Yoo, SY	1
Gosteva, EV; Vasil'eva, LV	1
D'Angelo, A; Derosa, G; Franzetti, I; Maffioli, P; Mugellini, A; Pesce, RM; Querci, F	1
Avram, S; Borcan, F; Borcan, LC; Duda-Seiman, C; Duda-Seiman, D; Mancas, S	1
Chazova, I; Coca, A; Girerd, X; Haller, H; Mancia, G; Omboni, S; Parati, G; Pauletto, P; Pupek-Musialik, D; Svyshchenko, Y	1
Bombelli, M; Brambilla, G; Casati, A; Cuspidi, C; Grassi, G; Mancia, G; Pizzalla, DP; Riva, M; Seravalle, G	1
D'Angelo, A; Derosa, G; Maffioli, P; Mugellini, A; Pesce, RM	1
Agabiti-Rosei, C; Agabiti-Rosei, E; Airò, P; Caimi, L; De Ciuceis, C; Ricotta, D; Rizzoni, D; Rossini, C; Ruggeri, G; Scarsi, M; Tincani, A	1
Arumugam, K; Averineni, RK; Deshpande, A; Deshpande, PB; Gurram, AK; Musmade, P; Mutalik, S; Reddy, MS; Shavi, GV; Udupa, N	1
Haiya, W; Ningyuan, F; Peixiao, S	1
Rizzoni, D	2
Parati, G	1
Dimitriadis, K; Mani, I; Mantzouranis, E; Tousoulis, D; Tsioufis, C; Tsioufis, K	1
Calvo, C; Espinel, E; Esteban, R; Macias, JF; Mateos, L; Robles, NR; Sobrino, J	1
Antza, C; Kotsis, V; Stabouli, S	1
de Vries, C; Haerden, Y; Lins, R	1
Cheng, KC; Cheng, KH; Cheng, KY; Lai, WT; Lee, CW; Yang, YH	1
Haller, H; Menne, J	1
Farah, R; Shurtz-Swirski, R	1
Barrios, V; Echarri, R; Escobar, C	1
Chin, D; Ferrucci, A; Pagannone, E; Palano, F; Tocci, G; Volpe, M	1
Burnier, M; Maillard, MP; Pruijm, MT	1
Brown, MJ; Cockcroft, JR; Dhakam, Z; Mackenzie, IS; McEniery, CM; Wilkinson, IB	1
Chia, YC; Chua, CT; Khoo, EM; Ng, CJ; Yeoh, ES	1
Chatzikyrkou, C; Haller, H; Menne, J	1
Burnier, M; Pruijm, M; Wuerzner, G	1
Ferrari, P; Glover-Koudounas, S; Makarounas-Kirchmann, K	1
Li, CJ; Shi, ZD	1
Bastos, MF; Brilhante, FV; Duarte, PM; Gonçalves, TE; Marques, MR; Napimoga, MH; Pires, AG	1
Rump, LC	1
Borghi, C; Cicero, AF	1
Kim, IS; Kim, Y; Lee, JJ; Lee, KH; Myung, CS; Park, HJ; Shin, CY; Zhang, WY	1
Sansanayudh, N; Veerayuthvilai, S; Wongwiwatthananukit, S	1
Schattner, A	1
Borghi, C; Cicero, AF; Gerocarni, B; Rosticci, M	1
Huang, J; Luo, M; Shen, Y; Xu, H; Zheng, H	1
Fomin, VV; Svistunov, AA	1
Iosava, IK; Minushkina, LO	1
Bastos, MF; Dias Gonçalves, TE; Duarte, PM; Marques, MR; Napimoga, MH; Pires, AG; Vasconcelos de Araújo, I; Vilhena Brilhante, F	1
Davies, P; James, IG; Jones, A	1
Levi, Z; Rachmani, R; Ravid, M; Zadok, BS	1
Leonetti, G; Magnani, B; Pessina, AC; Rappelli, A; Trimarco, B; Zanchetti, A	1
Bolla, G; Grassi, G; Mancia, G; Seravalle, G; Turri, C	1
Ghiadoni, L; Magagna, A; Salvetti, A; Salvetti, G; Taddei, S; Versari, D; Virdis, A	1
Helberg, S; Istad, H; Lund-Johansen, P; Madsbu, S; Risberg, K; Rønnevik, PK; Stranden, E; Wessel-Aas, T	1
Amenta, F; Peleg, E; Rosenthal, T; Sabbatini, M; Tomassoni, D	1
Ambrosioni, E; Borghi, C; Dormi, A; Prandin, MG	1
Aguilar, A; Angulo, E; Canelada, JA; Cidoncha, F; Díaz Olea, E; Fuentes, J; Garrido, J; Guerras, M; Hidalgo, P; Iglesias, M; Lapie, J; López Acedo, A; Peña, J; Robles, NR	1
Abellán Alemán, J; Fernández Montero, F; Gil Guillén, V; Latorre Hernández, J; Martínez García, JF; Merino Sánchez, J; Navarro Lima, A	1
Corradi, L; Derosa, G; Fogari, R; Mugellini, A; Preti, P; Rinaldi, A; Zoppi, A	1
Balbarini, A; Dell'Omo, G; Mariani, M; Menegato, A; Nuti, M; Pedrinelli, R	1
Greenough, A; McDonald, C; Millar-Craig, M; Mitchell, L; Shaffu, B	1
Ceriotti, F; Fedele, D; Lapolla, A; Mosca, A; Paleari, R	1
Bang, LM; Chapman, TM; Goa, KL	1
Bassous, M; Clerson, P; Goullard, L; Grès, CS; Poncelet, P; Ribstein, J	1
Christensen, KL	1
Calls, J; Gomez, CF; Herrera, J; Liebana, A; Manjon, M; Marco, J; Martinez, FI; Mendez, ML; Morey, A; Ocon, J; Pastor, L; Rincon, B; Robles, NR; Rodriguez, MM; Rodríguez, VI; Tornero, F; Torrijos, J; Villatoro, J	1
Aissi, K; Bagneres, D; Bonin-Guillaume, S; Coutant, G; Demoux, AL; Frances, Y; Grandel, B; Rossi, P	1
Campo, C; Parati, G; Roldán, C; Ruilope, LM; Saavedra, J; Segura, J	1
Crepaldi, G; Dalla Vestra, M; Fioretto, P; Grazioli, V; Lapolla, A; Mosca, A; Pozza, G	1
Agrawal, R; Haller, H; Marx, A	1
Coelho, EB; Gerlach, RF; Lopes, LF; Martinez, ML; Nobre, F; Rocha, JB; Tanus-Santos, JE	1
Agrawal, R; Bahlmann, FH; Bode-Böger, SM; Fliser, D; Haller, H; Kielstein, JT; Kirsch, T; Lindschau, C; Marx, A; Meier, M; Menne, J; Muller, D; Park, JK	1
Borghi, C	2
Burnier, M; Pechère, A; Waeber, B	1
Burnier, M; Meier, P	1
Barrios, L; Barrios, V; Calderón, A; Escobar, C; Navarro, A; Navarro-Cid, J	1
Ram, CV	2
Hair, PI; Perry, CM; Scott, LJ	1
Farah, R; Klempef, R; Kristal, B; Sela, S; Shapiro, G; Shurtz-Swirski, R; Snitkovski, T	1
Bueno-Gómez, J; Camacho-Azcargorta, I; Mora-Maciá, J; Navarro, A; Roma, J; Tisaire-Sánchez, J	1
Beckey, C; Lundy, A; Lutfi, N	1
Cuspidi, C; Grassi, G; Mancia, G; Quarti-Trevano, F; Scopelliti, F; Seravalle, G	1
Amenta, F; Rosenmann, E; Rosenthal, T; Tomassoni, D	1
Calvo, C; Ghezzi, C; Luurila, H; Luurila, O; Puig, JG; Strandberg, A; Sulosaari, S	1
Burnier, M; Gasser, UE	1
Borghi, C; Cicero, AF; Cosentino, E; Dormi, A; Prandin, MG; Strocchi, E; Veronesi, M	1
Barrios, V; Calderón, A; de la Figuera, M; Escobar, C; Honorato, J; Llisterri, JL; Segura, J	2
Bianchi, G; Greto, L; Leonardi, A; Montagna, E; Sironi, G; Testa, R	1
Mancia, G; Omboni, S; Zanchetti, A	1
Omboni, S; Zanchetti, A	1
Krzesinski, JM	1
Belcaro, G; Bucci, M; Cesarone, MR; Ciccarelli, R; De Sanctis, MT; Incandela, L; Ledda, A; Pellegrini, L; Steigerwalt, R	1
Barbagallo Sangiorgi, G; Barbagallo, M	1
Jarvis, B; McClellan, KJ	1
Amenta, F; Sabbatini, M; Tomassoni, D	2
Cleophas, TJ; van der Meulen, J; van Ouwerkerk, BM; Zwinderman, AH	1
Barsotti, A; Belcaro, G; Bucci, M; Cacchio, M; Cesarone, MR; Cornelli, U; De Sanctis, MT; Di Renzo, A; Griffin, M; Incandela, L; Martines, G; Nicolaides, AN	1
Barrios, V; Carrasco, JL; Esteras, A; Herranz, I; Luque, M; Navarro, A; Navarro-Cid, J; Prieto, L; Romero, J; Ruilope, LM; Tamargo, J	1
Viviani, GL	1

Reviews

30 review(s) available for lercanidipine and Hypertension

Article	Year
Antihypertensive treatment with calcium channel blockers and renal protection: focus on lercanidipine and lercanidipine/enalapril. European review for medical and pharmacological sciences, 2022, Volume: 26, Issue:20 Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Enalapril; Humans; Hypertension; Kidney	2022
New Insights into the Nephroprotective Potential of Lercanidipine. International journal of molecular sciences, 2023, Sep-13, Volume: 24, Issue:18 Topics: Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Humans; Hypertension; Renal Insufficiency, Chronic	2023
Lercanidipine-induced chylous ascites: Case report and literature review. Journal of clinical pharmacy and therapeutics, 2017, Volume: 42, Issue:5 Topics: Aged, 80 and over; Antihypertensive Agents; Calcium Channel Blockers; Chylous Ascites; Dihydropyridines; Female; Humans; Hypertension	2017
[THE ROLE PLEIOTROPIC EFFECTS OF CALCIUM CHANNEL BLOCKER LERCANIDIPINE IN PERIOPERATIVE THERAPY OF ARTERIAL HYPERTENSION.] Anesteziologiia i reanimatologiia, 2016, Volume: 61, Issue:5 Topics: Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Humans; Hypertension; Perioperative Care; Vascular Resistance	2016
[Clinical cfficacy of calcium channel blockers slow the third generation of lercanidipine in the treatment of patients with arterial hypertension]. Kardiologiia, 2013, Volume: 53, Issue:6 Topics: Antihypertensive Agents; Calcium Channel Blockers; Calcium Channels, L-Type; Dihydropyridines; Drug Therapy, Combination; Humans; Hypertension; Medication Therapy Management; Outcome Assessment, Health Care; Protective Agents; Treatment Outcome	2013
Renal protection with calcium antagonists: the role of lercanidipine. Current medical research and opinion, 2013, Volume: 29, Issue:12 Topics: Amlodipine; Calcium Channel Blockers; Dihydropyridines; Female; Humans; Hypertension; Kidney Failure, Chronic; Male; PubMed	2013
[Treatment of arteril hypertension in patients with chronic kidney disease: a fixed combination of lercanidipine and enalapril]. Kardiologiia, 2013, Volume: 53, Issue:12 Topics: Antihypertensive Agents; Blood Pressure; Dihydropyridines; Drug Combinations; Enalapril; Glomerular Filtration Rate; Humans; Hypertension; Renal Insufficiency, Chronic; Treatment Outcome	2013
[Third generation calcium antagonist lercanidipine: the evidence base for clinical decision]. Kardiologiia, 2014, Volume: 54, Issue:2 Topics: Calcium Channel Blockers; Dihydropyridines; Evidence-Based Medicine; Humans; Hypertension	2014
[Clinical efficacy of calcium channel blockers slow the third generation of lercanidipine in the treatment of patients with arterial hypertension and metabolic disorders (review)]. Georgian medical news, 2015, Issue:239 Topics: Angiotensin-Converting Enzyme Inhibitors; Calcium; Calcium Channel Blockers; Dihydropyridines; Drug Therapy, Combination; Humans; Hypertension; Metabolic Diseases; Risk Factors; Treatment Outcome	2015
Fixed-dose lercanidipine and enalapril in field practice: a meta-analysis. Current medical research and opinion, 2016, Volume: 32, Issue:sup2 Topics: Antihypertensive Agents; Blood Pressure; Dihydropyridines; Drug Therapy, Combination; Enalapril; Essential Hypertension; Female; Humans; Hypertension; Male; Middle Aged; Outcome Assessment, Health Care	2016
Dose-response effect of the lercanidipine/enalapril combination: a pooled analysis. Current medical research and opinion, 2016, Volume: 32, Issue:sup2 Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Dihydropyridines; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enalapril; Female; Humans; Hypertension; Male; Middle Aged	2016
Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence. Vascular health and risk management, 2016, Volume: 12 Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Drug Combinations; Enalapril; Evidence-Based Medicine; Humans; Hypertension; Patient Satisfaction; Treatment Outcome	2016
Fixed-dose lercanidipine/enalapril for hypertension. Drugs of today (Barcelona, Spain : 1998), 2008, Volume: 44, Issue:4 Topics: Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Dihydropyridines; Drug Combinations; Drug Interactions; Enalapril; Humans; Hypertension	2008
Fixed combinations in the management of hypertension: perspectives on lercanidipine-enalapril. Vascular health and risk management, 2008, Volume: 4, Issue:4 Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Drug Combinations; Enalapril; Humans; Hypertension; Treatment Outcome	2008
Fixed-combination therapies in hypertension management: focus on enalapril/lercanidipine. Expert review of cardiovascular therapy, 2009, Volume: 7, Issue:2 Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Clinical Trials as Topic; Dihydropyridines; Drug Combinations; Enalapril; Humans; Hypertension; Medication Adherence	2009
Patient adherence and the choice of antihypertensive drugs: focus on lercanidipine. Vascular health and risk management, 2008, Volume: 4, Issue:6 Topics: Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Drug Therapy, Combination; Humans; Hypertension; Medication Adherence; Proteinuria; Treatment Outcome	2008
The role of fixed-dose combinations in the management of hypertension: focus on lercanidipine-enalapril. Expert opinion on pharmacotherapy, 2009, Volume: 10, Issue:11 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Clinical Trials as Topic; Dihydropyridines; Drug Combinations; Enalapril; Humans; Hypertension	2009
Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine? Expert opinion on drug metabolism & toxicology, 2009, Volume: 5, Issue:8 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Calcium Channel Blockers; Dihydropyridines; Drug Combinations; Enalapril; Humans; Hypertension	2009
Results of a meta-analysis comparing the tolerability of lercanidipine and other dihydropyridine calcium channel blockers. Clinical therapeutics, 2009, Volume: 31, Issue:8 Topics: Antihypertensive Agents; Calcium Channel Blockers; Dihydropyridines; Edema; Humans; Hypertension; Randomized Controlled Trials as Topic; Treatment Outcome	2009
Rationale for the use of a fixed-dose combination in the management of hypertension: efficacy and tolerability of lercanidipine/enalapril. Clinical drug investigation, 2010, Volume: 30, Issue:12 Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Drug Combinations; Enalapril; Evidence-Based Medicine; Humans; Hypertension; Renin-Angiotensin System; Treatment Outcome	2010
[Lerkanidipin: evolution of dihydropyridine calcium antagonists continues]. Kardiologiia, 2012, Volume: 52, Issue:11 Topics: Age Factors; Aged; Atherosclerosis; Blood Pressure; Calcium Channel Blockers; Carotid Intima-Media Thickness; Dihydropyridines; Dose-Response Relationship, Drug; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Pharmacovigilance; Randomized Controlled Trials as Topic; Treatment Outcome	2012
[Lercanidipine in the treatment of arterial hypertension]. Kardiologiia, 2012, Volume: 52, Issue:12 Topics: Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Humans; Hypertension; Treatment Outcome	2012
Lercanidipine : a review of its efficacy in the management of hypertension. Drugs, 2003, Volume: 63, Issue:22 Topics: Calcium Channel Blockers; Clinical Trials as Topic; Dihydropyridines; Drug Interactions; Humans; Hypertension	2003
[Lercanidipine, a third generation calcium antagonist. Which advantages?]. Revue medicale suisse, 2006, Sep-13, Volume: 2, Issue:78 Topics: Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Controlled Clinical Trials as Topic; Dihydropyridines; Humans; Hypertension; Severity of Illness Index; Treatment Outcome	2006
Hypertension, possible vascular protection and lercanidipine. Expert review of cardiovascular therapy, 2006, Volume: 4, Issue:6 Topics: Calcium Channel Blockers; Dihydropyridines; Drug Therapy, Combination; Edema; Humans; Hypertension; Randomized Controlled Trials as Topic	2006
Fixed-dose combination lercanidipine/enalapril. Drugs, 2007, Volume: 67, Issue:1 Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Dihydropyridines; Drug Combinations; Enalapril; Humans; Hypertension	2007
Lercanidipine in hypertension. Vascular health and risk management, 2005, Volume: 1, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Humans; Hypertension; Middle Aged; Patient Compliance; Practice Guidelines as Topic; Severity of Illness Index; Treatment Outcome	2005
Lercanidipine in the treatment of hypertension. The Annals of pharmacotherapy, 2007, Volume: 41, Issue:3 Topics: Antihypertensive Agents; Calcium Channel Blockers; Clinical Trials as Topic; Dihydropyridines; Humans; Hypertension	2007
Clinical advantages of lipophilic dihydropyridines. Blood pressure. Supplement, 1998, Volume: 2 Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Dihydropyridines; Humans; Hypertension; Middle Aged; Randomized Controlled Trials as Topic; Tachycardia	1998
Lercanidipine: a review of its use in hypertension. Drugs, 2000, Volume: 60, Issue:5 Topics: Administration, Oral; Antihypertensive Agents; Blood Pressure; Diabetes Complications; Dihydropyridines; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Humans; Hypertension	2000

Trials

54 trial(s) available for lercanidipine and Hypertension

Article	Year
Effect of Lercanidipine on the Pharmacokinetics-Pharmacodynamics of Carvedilol Enantiomers in Patients With Chronic Kidney Disease. Journal of clinical pharmacology, 2020, Volume: 60, Issue:1 Topics: Administration, Oral; Adult; Antihypertensive Agents; Carvedilol; Case-Control Studies; Cross-Over Studies; Cytochrome P-450 Enzyme System; Dihydropyridines; Drug Interactions; Female; Glomerular Filtration Rate; Heart Rate; Humans; Hypertension; Male; Middle Aged; Renal Insufficiency, Chronic; Stereoisomerism	2020
Efficacy and safety of the treatment: combination of benazepril/lercanidipine vs. benazepril alone in patients with mild-to-moderate hypertension. Chinese medical journal, 2013, Volume: 126, Issue:12 Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Single-Blind Method	2013
Effects of enalapril/lercanidipine combination on some emerging biomarkers in cardiovascular risk stratification in hypertensive patients. Journal of clinical pharmacy and therapeutics, 2014, Volume: 39, Issue:3 Topics: Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; CD40 Ligand; Dihydropyridines; Double-Blind Method; Drug Combinations; Enalapril; Female; Humans; Hypertension; Lipids; Male; Middle Aged; Peroxidase; Risk Factors	2014
Enalapril/lercanidipine combination on markers of cardiovascular risk: a randomized study. Journal of the American Society of Hypertension : JASH, 2014, Volume: 8, Issue:6 Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Calcium Channel Blockers; Dihydropyridines; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Follow-Up Studies; Humans; Hypertension; Italy; Lipids; Male; Risk Factors; Survival Rate; Treatment Outcome	2014
Effects on office and home blood pressure of the lercanidipine-enalapril combination in patients with Stage 2 hypertension: a European randomized, controlled clinical trial. Journal of hypertension, 2014, Volume: 32, Issue:8 Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Double-Blind Method; Drug Combinations; Enalapril; Female; Humans; Hypertension; Male; Medication Adherence; Middle Aged	2014
Efficacy and safety evaluation of perindopril-lercanidipine combined therapy in patients with mild essential hypertension. Current medical research and opinion, 2015, Volume: 31, Issue:1 Topics: Adult; Aged; Antihypertensive Agents; Dihydropyridines; Drug Therapy, Combination; Essential Hypertension; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Perindopril; Treatment Outcome	2015
Efficacy and safety of lercanidipine/enalapril fixed combination in Lebanon: a prospective observational study. Current medical research and opinion, 2015, Volume: 31, Issue:1 Topics: Adult; Antihypertensive Agents; Dihydropyridines; Drug Combinations; Enalapril; Female; Heart Rate; Humans; Hypertension; Lebanon; Lipids; Male; Middle Aged; Prospective Studies; Treatment Outcome	2015
Lercanidipine hydrochloride versus felodipine sustained-release for mild-to-moderate hypertension: a multi-center, randomized clinical trial. Current medical research and opinion, 2015, Volume: 31, Issue:1 Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Delayed-Action Preparations; Dihydropyridines; Felodipine; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Treatment Outcome; Young Adult	2015
Effects of lercanidipine versus amlodipine in hypertensive patients with cerebral ischemic stroke. Current medical research and opinion, 2015, Volume: 31, Issue:1 Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure Monitoring, Ambulatory; Brain Ischemia; Dihydropyridines; Female; Humans; Hypertension; Male; Middle Aged; Stroke; Treatment Outcome	2015
Combination therapy with lercanidipine and enalapril reduced central blood pressure augmentation in hypertensive patients with metabolic syndrome. Vascular pharmacology, 2017, Volume: 92 Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Drug Therapy, Combination; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Italy; Male; Metabolic Syndrome; Middle Aged; Prospective Studies; Treatment Outcome; Vascular Stiffness	2017
Evaluation of the Efficacy and Safety of the Lercanidipine/Valsartan Combination in Korean Patients With Essential Hypertension Not Adequately Controlled With Lercanidipine Monotherapy: A Randomized, Multicenter, Parallel Design, Phase III Clinical Trial. Clinical therapeutics, 2015, Volume: 37, Issue:8 Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Dihydropyridines; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Essential Hypertension; Female; Headache; Humans; Hypertension; Male; Middle Aged; Treatment Outcome; Valsartan; Young Adult	2015
Barnidipine or Lercanidipine on Echocardiographic Parameters in Hypertensive, Type 2 Diabetics with Left Ventricular Hypertrophy: A Randomized Clinical Trial. Scientific reports, 2015, Aug-05, Volume: 5 Topics: Aged; Antihypertensive Agents; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Dihydropyridines; Double-Blind Method; Drug Therapy, Combination; Echocardiography; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Losartan; Male; Middle Aged; Nifedipine; Treatment Outcome	2015
Effects of the lercanidipine-enalapril combination vs. the corresponding monotherapies on home blood pressure in hypertension: evidence from a large database. Journal of hypertension, 2016, Volume: 34, Issue:1 Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Calcium Channel Blockers; Databases, Factual; Dihydropyridines; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Humans; Hypertension; Intention to Treat Analysis; Male; Middle Aged; Office Visits; Self Care	2016
Differential effects of enalapril-felodipine versus enalapril-lercanidipine combination drug treatment on sympathetic nerve traffic and metabolic profile in obesity-related hypertension. Journal of the American Society of Hypertension : JASH, 2016, Volume: 10, Issue:3 Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Cross-Over Studies; Dihydropyridines; Double-Blind Method; Drug Therapy, Combination; Enalapril; Felodipine; Female; Heart Rate; Humans; Hypertension; Insulin Resistance; Male; Metabolome; Middle Aged; Norepinephrine; Obesity; Random Allocation; Sympathetic Nervous System	2016
Barnidipine compared to lercanidipine in addition to losartan on endothelial damage and oxidative stress parameters in patients with hypertension and type 2 diabetes mellitus. BMC cardiovascular disorders, 2016, Apr-12, Volume: 16 Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Biomarkers; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Dihydropyridines; Double-Blind Method; Drug Therapy, Combination; Endothelium, Vascular; Female; Humans; Hypertension; Italy; Losartan; Male; Middle Aged; Nifedipine; Oxidative Stress; Time Factors; Treatment Outcome	2016
Effects of lercanidipine hydrochloride versus felodipine sustained-release on day-to-day home blood pressure variability. Current medical research and opinion, 2016, Volume: 32, Issue:sup2 Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Delayed-Action Preparations; Dihydropyridines; Felodipine; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Treatment Outcome	2016
Lercanidipine effect on circulating CD34+ progenitor cells in elderly patients: a randomized study. Current medical research and opinion, 2016, Volume: 32, Issue:sup2 Topics: Aged; Antigens, CD34; Antihypertensive Agents; Blood Pressure; Dihydropyridines; Female; Flow Cytometry; Hematopoietic Stem Cells; Humans; Hypertension; Male; Middle Aged	2016
Differential effects of lercanidipine/enalapril versus amlodipine/enalapril and hydrochlorothiazide/enalapril on target organ damage and sympathetic activation in non-obese essential hypertensive subjects. Current medical research and opinion, 2016, Volume: 32, Issue:sup2 Topics: Adult; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Dihydropyridines; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Kidney; Male; Middle Aged; Sympathetic Nervous System; Vascular Stiffness	2016
Lercanidipine valuable effect on urine protein losses: the RED LEVEL study. Current medical research and opinion, 2016, Volume: 32, Issue:sup2 Topics: Aged; Albuminuria; Amlodipine; Antihypertensive Agents; Blood Pressure; Dihydropyridines; Double-Blind Method; Enalapril; Female; Humans; Hypertension; Kidney; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Prospective Studies	2016
The combined effect of calcium channel blocker Lercanidipine and antioxidants on low-grade systemic inflammation parameters in essential hypertension patients. Minerva cardioangiologica, 2008, Volume: 56, Issue:5 Topics: Adult; Antioxidants; Calcium Channel Blockers; Dihydropyridines; Drug Therapy, Combination; Female; Humans; Hypertension; Inflammation; Male; Middle Aged	2008
Comparison of the effects of antihypertensive agents on central blood pressure and arterial stiffness in isolated systolic hypertension. Hypertension (Dallas, Tex. : 1979), 2009, Volume: 54, Issue:2 Topics: Administration, Oral; Aged; Analysis of Variance; Antihypertensive Agents; Arteries; Atenolol; Bendroflumethiazide; Blood Pressure Determination; Dihydropyridines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Elasticity; Female; Follow-Up Studies; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Multivariate Analysis; Patient Compliance; Perindopril; Probability; Regression Analysis; Risk Assessment; Systole; Treatment Outcome	2009
Efficacy and tolerability of the fixed lercanidipine-enalapril combination in the treatment of patients with essential hypertension. Arzneimittel-Forschung, 2010, Volume: 60, Issue:3 Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cohort Studies; Dihydropyridines; Drug Combinations; Enalapril; Female; Heart Rate; Humans; Hypertension; Lipids; Male; Middle Aged; Prospective Studies	2010
Comparison of changes of body water measured by using bioelectrical impedance analysis between lercanidipine and amlodipine therapy in hypertensive outpatients. Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2010, Volume: 93 Suppl 6 Topics: Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Body Composition; Body Water; Dihydropyridines; Edema; Electric Impedance; Extracellular Fluid; Female; Humans; Hypertension; Intracellular Fluid; Male; Middle Aged; Outpatients; Prospective Studies; Thailand; Treatment Outcome	2010
Blood pressure and metabolic effect of a combination of lercanidipine with different antihypertensive drugs in clinical practice. Clinical and experimental hypertension (New York, N.Y. : 1993), 2012, Volume: 34, Issue:2 Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Cholesterol; Dihydropyridines; Drug Therapy, Combination; Humans; Hypertension; Middle Aged; Triglycerides	2012
A randomised, double-blind, double-dummy comparison of the efficacy and tolerability of lercanidipine tablets and losartan tablets in patients with mild to moderate essential hypertension. Journal of human hypertension, 2002, Volume: 16, Issue:8 Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Blood Pressure; Dihydropyridines; Double-Blind Method; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Severity of Illness Index; Tablets	2002
Losartan and lercanidipine attenuate low-density lipoprotein oxidation in patients with hypertension and type 2 diabetes mellitus: a randomized, prospective crossover study. Clinical pharmacology and therapeutics, 2002, Volume: 72, Issue:3 Topics: Adult; Aged; Analysis of Variance; Antihypertensive Agents; Antioxidants; Cross-Over Studies; Diabetes Mellitus, Type 2; Dihydropyridines; Female; Humans; Hypertension; Lipoproteins, LDL; Losartan; Male; Middle Aged; Oxidation-Reduction; Prospective Studies; Single-Blind Method	2002
Tolerability of long-term treatment with lercanidipine versus amlodipine and lacidipine in elderly hypertensives. American journal of hypertension, 2002, Volume: 15, Issue:11 Topics: Aged; Amlodipine; Calcium Channel Blockers; Dihydropyridines; Double-Blind Method; Drug Therapy, Combination; Edema; Female; Humans; Hypertension; Male; Peripheral Vascular Diseases; Treatment Outcome	2002
Short-versus long-term effects of different dihydropyridines on sympathetic and baroreflex function in hypertension. Hypertension (Dallas, Tex. : 1979), 2003, Volume: 41, Issue:3 Topics: Antihypertensive Agents; Baroreflex; Blood Pressure; Dihydropyridines; Double-Blind Method; Felodipine; Heart Rate; Humans; Hypertension; Male; Middle Aged; Muscle, Skeletal; Norepinephrine; Sympathetic Nervous System; Time Factors	2003
Calcium antagonist treatment by lercanidipine prevents hyperpolarization in essential hypertension. Hypertension (Dallas, Tex. : 1979), 2003, Volume: 41, Issue:4 Topics: Antioxidants; Ascorbic Acid; Calcium Channel Blockers; Dihydropyridines; Endothelium, Vascular; Female; Forearm; Humans; Hypertension; Male; Middle Aged; Nitric Oxide; Oxidative Stress; Regional Blood Flow; Vasodilation	2003
Quantification of leg oedema in postmenopausal hypertensive patients treated with lercanidipine or amlodipine. Journal of hypertension, 2003, Volume: 21, Issue:5 Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Volume; Calcium Channel Blockers; Diastole; Dihydropyridines; Drug Evaluation; Edema; Female; Heart Rate; Humans; Hypertension; Leg; Middle Aged; Norway; Postmenopause; Statistics as Topic; Systole; Time Factors; Treatment Outcome; Women's Health	2003
Improved tolerability of the dihydropyridine calcium-channel antagonist lercanidipine: the lercanidipine challenge trial. Blood pressure. Supplement, 2003, Volume: 1 Topics: Aged; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Edema; Endpoint Determination; Female; Flushing; Headache; Heart Rate; Humans; Hypertension; Male; Middle Aged; Patient Dropouts	2003
[Evaluation of lercanidipine in the general practice setting]. Anales de medicina interna (Madrid, Spain : 1984), 2003, Volume: 20, Issue:6 Topics: Aged; Antihypertensive Agents; Calcium Channel Blockers; Calcium Channels, L-Type; Cholesterol; Diabetes Complications; Dihydropyridines; Family Practice; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Hypertension; Male; Middle Aged; Obesity; Treatment Outcome; Uric Acid	2003
[Evaluation of psychosomatic symptomatology in hypertensive patients treated with lercanidipine (LERCAPSICO study)]. Anales de medicina interna (Madrid, Spain : 1984), 2003, Volume: 20, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Anxiety; Blood Glucose; Calcium Channel Blockers; Calcium Channels, L-Type; Cholesterol; Diabetes Complications; Diabetes Mellitus; Dihydropyridines; Female; Humans; Hypercholesterolemia; Hypertension; Male; Middle Aged; Prospective Studies; Psychophysiologic Disorders; Treatment Outcome	2003
Differential effects of lercanidipine and nifedipine GITS on plasma norepinephrine in chronic treatment of hypertension. American journal of hypertension, 2003, Volume: 16, Issue:7 Topics: Adult; Aged; Calcium Channel Blockers; Dihydropyridines; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Nifedipine; Norepinephrine	2003
Heterogeneous effect of calcium antagonists on leg oedema: a comparison of amlodipine versus lercanidipine in hypertensive patients. Journal of hypertension, 2003, Volume: 21, Issue:10 Topics: Adult; Amlodipine; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Dihydropyridines; Edema; Humans; Hypertension; Laser-Doppler Flowmetry; Leg; Male; Middle Aged; Skin; Treatment Outcome; Vasoconstriction	2003
Lercanidipine vs lacidipine in isolated systolic hypertension. Journal of human hypertension, 2003, Volume: 17, Issue:11 Topics: Aged; Aged, 80 and over; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Dihydropyridines; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Supine Position; Treatment Outcome	2003
Biological variability of albumin excretion rate and albumin-to-creatinine ratio in hypertensive type 2 diabetic patients. Clinical chemistry and laboratory medicine, 2003, Volume: 41, Issue:9 Topics: Albuminuria; Calcium Channel Blockers; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dihydropyridines; Humans; Hypertension; Protein Denaturation; Sensitivity and Specificity; Serum Albumin; Temperature	2003
[Efficacy and acceptability of lercanidipine are not age dependent in patients with essential hypertension: the AGATE study]. Annales de cardiologie et d'angeiologie, 2004, Volume: 53, Issue:3 Topics: Age Factors; Aged; Antihypertensive Agents; Blood Pressure; Dihydropyridines; Edema; Female; Humans; Hypertension; Leg; Male; Middle Aged; Treatment Outcome	2004
Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL study (diabete, ipertensione, albuminuria, lercanidipina). Diabetes, nutrition & metabolism, 2004, Volume: 17, Issue:5 Topics: Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dihydropyridines; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Ramipril; Treatment Outcome	2004
Efficacy and safety of lercanidipine versus hydrochlorothiazide as add-on to enalapril in diabetic populations with uncontrolled hypertension. Journal of hypertension, 2006, Volume: 24, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dihydropyridines; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Single-Blind Method	2006
Lercanidipine reduces matrix metalloproteinase-9 activity in patients with hypertension. Journal of cardiovascular pharmacology, 2006, Volume: 47, Issue:1 Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Cross-Over Studies; Dihydropyridines; Female; Humans; Hypertension; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Middle Aged; Oxidative Stress; Single-Blind Method; Tissue Inhibitor of Metalloproteinase-1	2006
Assessment of cognitive function in patients with essential hypertension treated with lercanidipine. Vascular health and risk management, 2006, Volume: 2, Issue:4 Topics: Adrenergic alpha-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cognition; Dihydropyridines; Doxazosin; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Longitudinal Studies; Male; Middle Aged; Psychiatric Status Rating Scales; Psychomotor Performance; Spain; Time Factors; Treatment Outcome	2006
Effects of long-term lercanidipine or hydrochlorothiazide administration on hypertension-related vascular structural changes. Blood pressure, 2006, Volume: 15, Issue:5 Topics: Blood Vessels; Calcium Channel Blockers; Case-Control Studies; Dihydropyridines; Diuretics; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy; Male; Middle Aged; Vascular Resistance	2006
Lercanidipine, enalapril and their combination in the treatment of elderly hypertensive patients: placebo-controlled, randomized, crossover study with four ABPM. Journal of human hypertension, 2007, Volume: 21, Issue:12 Topics: Aged; Antihypertensive Agents; Blood Pressure Monitoring, Ambulatory; Cross-Over Studies; Diastole; Dihydropyridines; Drug Therapy, Combination; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Placebos; Systole; Time Factors	2007
Efficacy and tolerability of lercanidipine in patients with hypertension: results of a Phase IV study in general practice. Expert opinion on pharmacotherapy, 2007, Volume: 8, Issue:14 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Pressure; Dihydropyridines; Family Practice; Female; Humans; Hypertension; Male; Middle Aged; Product Surveillance, Postmarketing; Sexual Dysfunction, Physiological; Sleep Wake Disorders	2007
A prospective evaluation of persistence on antihypertensive treatment with different antihypertensive drugs in clinical practice. Vascular health and risk management, 2007, Volume: 3, Issue:6 Topics: Adrenergic beta-Antagonists; Age Factors; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Dihydropyridines; Diuretics; Dose-Response Relationship, Drug; Female; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Sex Factors	2007
High doses of lercanidipine are better tolerated than other dihydropyridines in hypertensive patients with metabolic syndrome: results from the TOLERANCE study. International journal of clinical practice, 2008, Volume: 62, Issue:5 Topics: Adolescent; Adult; Aged; Amlodipine; Antihypertensive Agents; Calcium Channel Blockers; Cross-Sectional Studies; Dihydropyridines; Dose-Response Relationship, Drug; Female; Humans; Hypertension; Male; Metabolic Syndrome; Middle Aged; Nifedipine	2008
Tolerability of high doses of lercanidipine versus high doses of other dihydropyridines in daily clinical practice: the TOLERANCE Study. Cardiovascular therapeutics, 2008,Spring, Volume: 26, Issue:1 Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cross-Sectional Studies; Dihydropyridines; Female; Heart Rate; Humans; Hypertension; Logistic Models; Male; Middle Aged; Nifedipine; Primary Health Care; Spain; Vasodilation	2008
Antihypertensive efficacy of lercanidipine at 2.5, 5 and 10 mg in mild to moderate essential hypertensives assessed by clinic and ambulatory blood pressure measurements. Multicenter Study Investigators. Journal of hypertension, 1998, Volume: 16, Issue:12 Pt 1 Topics: Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Dihydropyridines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Evaluation; Female; Humans; Hypertension; Male; Middle Aged	1998
Pressure and microcirculatory effects of treatment with lercanidipine in hypertensive patients and in vascular patients with hypertension. Angiology, 2000, Volume: 51, Issue:8 Pt 2 Topics: Adult; Aged; Antihypertensive Agents; Dihydropyridines; Female; Humans; Hypertension; Laser-Doppler Flowmetry; Male; Microcirculation; Middle Aged; Retinal Artery; Treatment Outcome; Ultrasonography; Vascular Diseases	2000
Efficacy and tolerability of lercanidipine in monotherapy in elderly patients with isolated systolic hypertension. Aging (Milan, Italy), 2000, Volume: 12, Issue:5 Topics: Aged; Antihypertensive Agents; Blood Pressure; Diastole; Dihydropyridines; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Systole; Treatment Outcome	2000
Diabetics with hypertension not controlled with ACE inhibitors: alternate therapies. Angiology, 2001, Volume: 52, Issue:7 Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Dihydropyridines; Drug Therapy, Combination; Enalapril; Female; Glycated Hemoglobin; Humans; Hypertension; Male; Metoprolol; Middle Aged; Regression Analysis; Vascular Resistance	2001
Antihypertensive efficacy and tolerability of lercanidipine in daily clinical practice. The ELYPSE Study. Eficacia de Lercanidipino y su Perfil de Seguridad. Blood pressure, 2002, Volume: 11, Issue:2 Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Drug Tolerance; Female; Humans; Hypertension; Male; Middle Aged; Patient Compliance; Patient Dropouts; Prospective Studies	2002
Lercanidipine in type II diabetic patients with mild to moderate arterial hypertension. Journal of cardiovascular pharmacology, 2002, Volume: 40, Issue:1 Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Area Under Curve; Blood Glucose; Chi-Square Distribution; Diabetes Mellitus, Type 2; Dihydropyridines; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Single-Blind Method	2002

Other Studies

56 other study(ies) available for lercanidipine and Hypertension

Article	Year
Enalapril-lercanidipine combination induced leukocytoclastic vasculitis: A case report. British journal of clinical pharmacology, 2021, Volume: 87, Issue:1 Topics: Dihydropyridines; Enalapril; Humans; Hypertension; Vasculitis, Leukocytoclastic, Cutaneous	2021
Comparison of lercanidipine plus hydrochlorothiazide vs. lercanidipine plus enalapril on micro and macrocirculation in patients with mild essential hypertension. Internal and emergency medicine, 2017, Volume: 12, Issue:7 Topics: Adult; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Drug Therapy, Combination; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged	2017
Effects on 24-hour blood pressure variability of ace-inhibition and calcium channel blockade as monotherapy or in combination. Scientific reports, 2018, 09-13, Volume: 8, Issue:1 Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium; Calcium Channel Blockers; Calcium Channels; Dihydropyridines; Enalapril; Female; Humans; Hypertension; Male; Middle Aged	2018
Current perspective on the use of calcium channel blockers to treat hypertensive patients: the role of lercanidipine. Future cardiology, 2019, Volume: 15, Issue:4 Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Dihydropyridines; Drug Therapy, Combination; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Practice Guidelines as Topic; Precision Medicine	2019
Calcium channel blocker effect on insulin resistance and inflammatory markers in essential hypertension patients. International angiology : a journal of the International Union of Angiology, 2013, Volume: 32, Issue:1 Topics: Adult; Aged; Calcium Channel Blockers; Dihydropyridines; Female; Humans; Hypertension; Inflammation Mediators; Insulin Resistance; Male; Middle Aged; Prospective Studies; Young Adult	2013
Calcium Antagonists Use and Its Association with Lower Urinary Tract Symptoms: A Cross-Sectional Study. PloS one, 2013, Volume: 8, Issue:6 Topics: Aged; Calcium Channel Blockers; Cross-Sectional Studies; Dihydropyridines; Felodipine; Female; Humans; Hypertension; Interviews as Topic; Logistic Models; Lower Urinary Tract Symptoms; Male; Middle Aged; Odds Ratio; Severity of Illness Index; Surveys and Questionnaires	2013
CXCR7 upregulation is required for early endothelial progenitor cell-mediated endothelial repair in patients with hypertension. Hypertension (Dallas, Tex. : 1979), 2014, Volume: 63, Issue:2 Topics: Animals; Antihypertensive Agents; Apoptosis; Carotid Artery Injuries; Caspase 3; Cell Adhesion; Cells, Cultured; Dihydropyridines; Endothelial Cells; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Human Umbilical Vein Endothelial Cells; Humans; Hypertension; Male; MAP Kinase Signaling System; Mice; Mice, Nude; Receptors, CXCR; Transfection; Up-Regulation	2014
Effect of antihypertensive treatment on microvascular structure, central blood pressure and oxidative stress in patients with mild essential hypertension. Journal of hypertension, 2014, Volume: 32, Issue:3 Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arterioles; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Diuretics; Drug Therapy, Combination; Enalapril; Essential Hypertension; Female; Humans; Hydrochlorothiazide; Hypertension; Kidney; Laser-Doppler Flowmetry; Male; Middle Aged; Oxidative Stress; Ultrasonography	2014
Second generation lipid nanoparticles (NLC) as an oral drug carrier for delivery of lercanidipine hydrochloride. Colloids and surfaces. B, Biointerfaces, 2014, Apr-01, Volume: 116 Topics: Administration, Oral; Animals; Blood Pressure; Calcium; Diffusion; Dihydropyridines; Drug Carriers; Drug Delivery Systems; Hypertension; Kinetics; Lipids; Male; Molecular Structure; Nanoparticles; Particle Size; Rats; Rats, Sprague-Dawley; Surface Properties	2014
Effect of antihypertensive treatments on insulin signalling in lympho-monocytes of essential hypertensive patients: a pilot study. Blood pressure, 2014, Volume: 23, Issue:6 Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Dihydropyridines; Drug Combinations; Enalapril; Essential Hypertension; Female; Glucose Transporter Type 4; Humans; Hypertension; Insulin; Lymphocytes; Male; Middle Aged; Monocytes; Nifedipine; Pilot Projects; Signal Transduction; TOR Serine-Threonine Kinases	2014
Efficacy and safety of a lercanidipine/enalapril fixed-dose combination in hypertensive patients in Portugal. Drugs in R&D, 2014, Volume: 14, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Dihydropyridines; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Patient Safety; Portugal	2014
Gingival overgrowth as secondary effect of calcium channel blockers administration. A case report. Journal of medicine and life, 2014, Jun-15, Volume: 7, Issue:2 Topics: Calcium Channel Blockers; Dental Prophylaxis; Denture, Partial; Dihydropyridines; Female; Gingival Overgrowth; Gingivectomy; Humans; Hypertension; Middle Aged	2014
Can lercanidipine improve renal function in patients with atherosclerotic renal artery stenosis undergoing renal artery intervention? Current medical research and opinion, 2015, Volume: 31, Issue:1 Topics: Adult; Aged; Angioplasty, Balloon; Antihypertensive Agents; Atherosclerosis; Blood Pressure Monitoring, Ambulatory; Cohort Studies; Creatinine; Dihydropyridines; Female; Glomerular Filtration Rate; Humans; Hypertension; Male; Middle Aged; Pulse Wave Analysis; Renal Artery Obstruction; Stents; Treatment Outcome	2015
Lercanidipine in worldwide usage. Current medical research and opinion, 2015, Volume: 31, Issue:1 Topics: Antihypertensive Agents; China; Dihydropyridines; Humans; Hypertension; Lebanon; Vietnam	2015
Single-pill combination therapy in the initial treatment of marked hypertension: a propensity-matched analysis. Clinical and experimental hypertension (New York, N.Y. : 1993), 2015, Volume: 37, Issue:5 Topics: Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Dihydropyridines; Dose-Response Relationship, Drug; Drug Combinations; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Perindopril; Propensity Score; Ramipril; Retrospective Studies; Risk Factors; Telmisartan; Tetrazoles	2015
[Effect of Fixed Lercanidipine/Enalapril Combination on 24-Hour Blood Pressure Proffie in Elderly Patients With Arterial Hypertension]. Kardiologiia, 2015, Volume: 55, Issue:2 Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Dihydropyridines; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enalapril; Female; Follow-Up Studies; Humans; Hypertension; Male; Treatment Outcome	2015
Calcium Channel Blockers--Benefits Upon Vascular Biology in Hypertensive Patients. Cardiovascular & hematological agents in medicinal chemistry, 2015, Volume: 13, Issue:1 Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Female; Humans; Hypertension; Male; Middle Aged; Pulse Wave Analysis; Vascular Stiffness	2015
Effect of antihypertensive treatment with lercanidipine on endothelial progenitor cells and inflammation in patients with mild to moderate essential hypertension. Blood pressure, 2016, Volume: 25, Issue:6 Topics: Antihypertensive Agents; Dihydropyridines; Endothelial Progenitor Cells; Essential Hypertension; Female; Humans; Hypertension; Inflammation; Male; Middle Aged; Risk Factors	2016
A novel nanoproliposomes of lercanidipine: Development, in vitro and preclinical studies to support its effectiveness in hypertension therapy. Life sciences, 2016, Oct-01, Volume: 162 Topics: Animals; Antihypertensive Agents; Calorimetry, Differential Scanning; Dihydropyridines; Hypertension; In Vitro Techniques; Liposomes; Nanoparticles; Rabbits; Rats; Rats, Wistar; X-Ray Diffraction	2016
Vascular effects of the lercanidipine/enalapril combination: clinical relevance. Current medical research and opinion, 2016, Volume: 32, Issue:sup2 Topics: Antihypertensive Agents; Blood Pressure; Blood Vessels; Dihydropyridines; Drug Therapy, Combination; Enalapril; Humans; Hypertension	2016
Replacement of Amlodipine and Lercanidipine by Barnidipine: Tolerability and Effectiveness in a Real-Life Study. High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension, 2017, Volume: 24, Issue:1 Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Drug Substitution; Female; Humans; Hypertension; Male; Middle Aged; Nifedipine; Product Surveillance, Postmarketing; Prospective Studies; Time Factors; Treatment Outcome	2017
Long-term outcomes of lercanidipine versus other calcium channel blockers in newly diagnosed hypertension: a nationwide cohort study. Current medical research and opinion, 2017, Volume: 33, Issue:6 Topics: Adolescent; Adult; Aged; Amlodipine; Blood Pressure; Calcium Channel Blockers; Cohort Studies; Dihydropyridines; Felodipine; Female; Humans; Hypertension; Male; Middle Aged; Retrospective Studies; Stroke; Taiwan; Young Adult	2017
Efficacy and tolerability of lercanidipine in mild to moderate hypertension among Asians of different ethnic groups. Singapore medical journal, 2009, Volume: 50, Issue:5 Topics: Antihypertensive Agents; Asia; Calcium Channel Blockers; Confidence Intervals; Diastole; Dihydropyridines; Female; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Singapore; Systole	2009
Calcium channel blocker. Clinical therapeutics, 2010, Volume: 32, Issue:2 Topics: Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Data Interpretation, Statistical; Dihydropyridines; Edema; Humans; Hypertension; Meta-Analysis as Topic; Risk Assessment; Treatment Outcome	2010
Hypertension may affect tooth-supporting alveolar bone quality: a study in rats. Journal of periodontology, 2010, Volume: 81, Issue:7 Topics: Acid Phosphatase; Alveolar Bone Loss; Alveolar Process; Animals; Antihypertensive Agents; Biomarkers; Bone Density; Dihydropyridines; Hypertension; Immunohistochemistry; Isoenzymes; Male; Molar; Osteoprotegerin; RANK Ligand; Rats; Rats, Inbred SHR; Rats, Wistar; Tartrate-Resistant Acid Phosphatase; Tooth Root	2010
Drug synergism of antihypertensive action in combination of telmisartan with lercanidipine in spontaneous hypertensive rats. Archives of pharmacal research, 2010, Volume: 33, Issue:9 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Dose-Response Relationship, Drug; Drug Synergism; Heart Rate; Hypertension; Kinetics; Male; Random Allocation; Rats; Rats, Inbred SHR; Statistics as Topic; Telmisartan	2010
Lercanidipine-associated nocturia. QJM : monthly journal of the Association of Physicians, 2011, Volume: 104, Issue:5 Topics: Antihypertensive Agents; Dihydropyridines; Humans; Hypertension; Male; Middle Aged; Nocturia	2011
[Fixed combination enalapril/lercanidipine in routine treatment: consistent RR reduction with kidney protection]. MMW Fortschritte der Medizin, 2011, Jan-20, Volume: 153, Issue:3 Topics: Antihypertensive Agents; Dihydropyridines; Drug Combinations; Electrocardiography; Enalapril; Humans; Hypertension; Kidney Function Tests; Proteinuria	2011
[ACE inhibitor and calcium antagonist in fixed combination: effective protection for hypertensive patients at risk]. MMW Fortschritte der Medizin, 2012, Feb-09, Volume: 154, Issue:2 Topics: Albuminuria; Antihypertensive Agents; Blood Pressure; Combined Modality Therapy; Dihydropyridines; Drug Combinations; Enalapril; Humans; Hypertension; Physical Fitness; Stroke	2012
Polymorphism of the methylenetetrahydrofolate reductase gene C677T and its influence on the antihypertensive and vascular protective effects of short-term lercanidipine treatment. Gene, 2012, Jun-01, Volume: 500, Issue:2 Topics: Adult; Ankle Brachial Index; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Female; Genotype; Humans; Hypertension; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Phenotype; Polymorphism, Genetic; Time Factors	2012
Effects of lercanidipine on bone density and bone repair in spontaneously hypertensive rats. Implant dentistry, 2013, Volume: 22, Issue:1 Topics: Acid Phosphatase; Animals; Antihypertensive Agents; Biomarkers; Bone Density; Bone Diseases; Bone Regeneration; Calcium Channel Blockers; Dihydropyridines; Hypertension; Image Processing, Computer-Assisted; Isoenzymes; Male; Rats; Rats, Inbred SHR; Rats, Wistar; Tartrate-Resistant Acid Phosphatase; Tibia; Wound Healing	2013
[Depot calcium antagonist. General practice study confirms good tolerance]. MMW Fortschritte der Medizin, 2003, Jan-30, Volume: 145, Issue:5 Topics: Antihypertensive Agents; Calcium Channel Blockers; Clinical Trials as Topic; Delayed-Action Preparations; Dihydropyridines; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Hypertension	2003
Effect of treatment with lercanidipine on heart of Cohen-Rosenthal diabetic hypertensive rats. Hypertension (Dallas, Tex. : 1979), 2003, Volume: 41, Issue:6 Topics: Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Calcium Channel Blockers; Coronary Vessels; Diabetes Mellitus, Type 2; Dihydropyridines; Heart; Hypertension; Male; Myocardium; Organ Size; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Rats, Inbred WKY	2003
[Therapy of hypertension is mostly combination therapy. Calcium antagonists are ideal partners]. MMW Fortschritte der Medizin, 2003, Jun-26, Volume: 145, Issue:26 Topics: Antihypertensive Agents; Calcium Channel Blockers; Clinical Trials as Topic; Dihydropyridines; Drug Therapy, Combination; Humans; Hypertension	2003
[Most hypertensive patients need drug combination treatment. "First line therapy is in second place"]. MMW Fortschritte der Medizin, 2003, Aug-21, Volume: 145, Issue:33-34 Topics: Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Clinical Trials as Topic; Dihydropyridines; Drug Therapy, Combination; Humans; Hypertension; Nitrendipine	2003
[Drug information about lercanidipine. A new dihydropyridine calcium antagonist for the treatment of arterial hypertension]. Ugeskrift for laeger, 2005, Jan-10, Volume: 167, Issue:2 Topics: Antihypertensive Agents; Calcium Channel Blockers; Contraindications; Dihydropyridines; Drug Interactions; Humans; Hypertension	2005
Lercanidipine in patients with chronic renal failure: the ZAFRA study. Renal failure, 2005, Volume: 27, Issue:1 Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Dihydropyridines; Female; Humans; Hypertension; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Treatment Outcome	2005
[Lowering blood pressure with new calcium antagonists. High benefit by innovative mechanism of action]. MMW Fortschritte der Medizin, 2005, Feb-03, Volume: 147, Issue:5 Topics: Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Drug Administration Schedule; Endothelium, Vascular; Humans; Hypertension; Patient Compliance; Treatment Outcome	2005
[Also for problem cases; successful first line therapy]. MMW Fortschritte der Medizin, 2005, Feb-03, Volume: 147, Issue:5 Topics: Antihypertensive Agents; Arteriosclerosis; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Humans; Hypertension; Treatment Outcome	2005
[What chance is there that the patient will be treated!]. La Revue de medecine interne, 2005, Volume: 26 Suppl 2 Topics: Antihypertensive Agents; Chylous Ascites; Dihydropyridines; Humans; Hypertension; Male; Middle Aged	2005
Correlations of smoothness index and trough-to-peak ratio with left ventricular mass index changes induced by lercanidipine in hypertensive patients. A pilot trial. Minerva medica, 2005, Volume: 96, Issue:5 Topics: Adult; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Dihydropyridines; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Pilot Projects; Prospective Studies	2005
Cellular and molecular mechanisms of tissue protection by lipophilic calcium channel blockers. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2006, Volume: 20, Issue:7 Topics: Albumins; Amidohydrolases; Angiotensin II; Angiotensinogen; Animals; Animals, Genetically Modified; Arginine; Calcium Channel Blockers; Dihydropyridines; Gene Expression Regulation, Enzymologic; Hypertension; Kidney; Rats; Rats, Sprague-Dawley; Renin	2006
[Hypertensive patients can benefit from a new generation of calcium channel blockers. Lercanidipine: effective with few side effects]. Revue medicale suisse, 2006, May-10, Volume: 2, Issue:65 Topics: Calcium Channel Blockers; Dihydropyridines; Humans; Hypertension	2006
[Antihypertensive agents used as first line agents: beta-blockers under pressure]. Revue medicale suisse, 2006, Sep-13, Volume: 2, Issue:78 Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Dihydropyridines; Diuretics; Drug Therapy, Combination; Eplerenone; Humans; Hypertension; Spironolactone; Treatment Outcome	2006
Lercanidipine is an effective and well tolerated antihypertensive drug regardless the cardiovascular risk profile: The LAURA study. International journal of clinical practice, 2006, Volume: 60, Issue:11 Topics: Aged; Analysis of Variance; Antihypertensive Agents; Dihydropyridines; Female; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Risk Factors; Treatment Outcome	2006
[The effect of calcium channel blocker lercanidipine on lowgrade inflammation parameters in essential hypertension patients]. Harefuah, 2006, Volume: 145, Issue:12 Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Humans; Hypertension; Inflammation; Middle Aged; Neutrophils	2006
Effect of lercanidipine on kidney microanatomy in Cohen-Rosenthal diabetic hypertensive rats. Journal of cardiovascular pharmacology and therapeutics, 2007, Volume: 12, Issue:2 Topics: Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Experimental; Dihydropyridines; Disease Models, Animal; Hypertension; Kidney; Male; Rats; Renal Artery; Renal Circulation	2007
Antihypertensive effects of lercanidipine in experimental hypertensive rats and dogs. Arzneimittel-Forschung, 1996, Volume: 46, Issue:2 Topics: Administration, Oral; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Catheterization; Dihydropyridines; Dogs; Heart Rate; Hypertension; Hypertension, Renal; Injections, Intravenous; Male; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley	1996
[Pharma-clinics. Drug of the month. Lercanidipine (Zanidip)]. Revue medicale de Liege, 1999, Volume: 54, Issue:10 Topics: Antihypertensive Agents; Blood Pressure; Dihydropyridines; Half-Life; Humans; Hypertension	1999
[Modern calcium channel blockade. Lowering blood pressure with added benefits]. MMW Fortschritte der Medizin, 2001, Feb-08, Volume: 143, Issue:6 Topics: Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Humans; Hypertension	2001
Influence of treatment with Ca(2+) antagonists on cerebral vasculature of spontaneously hypertensive rats. Mechanisms of ageing and development, 2001, Volume: 122, Issue:8 Topics: Animals; Antihypertensive Agents; Blood Pressure; Brain; Calcium Channel Blockers; Cerebrovascular Circulation; Dihydropyridines; Hydralazine; Hypertension; Male; Nimodipine; Nitrobenzenes; Piperazines; Rats; Rats, Inbred SHR; Rats, Wistar	2001
[Hypertension in type 2 diabetic patients. Calcium antagonist supports the left heart]. MMW Fortschritte der Medizin, 2001, Jun-21, Volume: 143, Issue:25 Topics: Antihypertensive Agents; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Dihydropyridines; Follow-Up Studies; Humans; Hypertension; Hypertrophy, Left Ventricular; Treatment Outcome	2001
Oxygen-free radical decrease in hypertensive patients treated with lercanidipine. International angiology : a journal of the International Union of Angiology, 2001, Volume: 20, Issue:2 Topics: Adult; Antihypertensive Agents; Blood Pressure; Dihydropyridines; Electrocardiography; Female; Free Radicals; Heart Rate; Humans; Hypertension; Male; Middle Aged; Oxidative Stress; Oxygen; Time Factors	2001
Hypertensive brain damage: comparative evaluation of protective effect of treatment with dihydropyridine derivatives in spontaneously hypertensive rats. Mechanisms of ageing and development, 2001, Volume: 122, Issue:16 Topics: Animals; Antihypertensive Agents; Blood Pressure; Brain; Brain Injuries; Calcium Channel Blockers; Dihydropyridines; Frontal Lobe; Hippocampus; Hypertension; Male; Nimodipine; Nitrobenzenes; Occipital Lobe; Piperazines; Rats; Rats, Inbred SHR; Rats, Inbred WKY	2001
[New calcium antagonist. Therapy of hypertension becomes more tolerable]. MMW Fortschritte der Medizin, 2001, Oct-04, Volume: 143, Issue:40 Topics: Calcium Channel Blockers; Dihydropyridines; Drug Approval; Germany; Humans; Hypertension	2001
Usefulness of lercanidipine, a new calcium antagonist, for systemic hypertension. The American journal of cardiology, 2002, Jan-15, Volume: 89, Issue:2 Topics: Animals; Ankle; Calcium Channel Blockers; Dihydropyridines; Edema; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney	2002